COSTA MESA, Calif., and Albany, N.Y., Feb. 8, 2016/ Weed Wire/ —NEMUS Bioscience, Inc. (OTCQB: NMUS) today announced an agreement with Albany Molecular Research Inc. (NASDAQ: AMRI) for the development and manufacture of NEMUS’ proprietary cannabinoid-based active pharmaceutical ingredients.